World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
153
Citations
110265
World Ranking
1023
National Ranking
582

Daniel J. Weisdorf publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Daniel J. Weisdorf sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 1,228 publications — 97th percentile

97% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Daniel J. Weisdorf D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Daniel J. Weisdorf sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 153 D-Index — 95th percentile

95% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Daniel J. Weisdorf is affiliated with the University of Minnesota in the United States and has contributed extensively to the field of medical research, particularly in hematology and oncology.

Their research spans diverse topics, with significant focus on hematopoietic stem cell transplantation and leukemia. Key areas of study include:

  • Hematopoietic Stem Cell Transplantation
  • Acute Myeloid Leukemia Research
  • Acute Lymphoblastic Leukemia Research
  • Childhood Cancer Survivors' Quality of Life
  • Neutropenia and Cancer Infections
  • Immune Cell Function and Interaction
  • Gut Microbiota and Health

Their main fields of study cover:

  • Medicine

Within medicine, specific subfields of research activity have included:

  • Hematology
  • Oncology
  • Public Health, Environmental and Occupational Health
  • Immunology
  • Molecular Biology

Daniel J. Weisdorf has published numerous scientific papers. Notable recent publications include:

  • "Current Use of and Trends in Hematopoietic Cell Transplantation in the United States" (2020) in Biology of Blood and Marrow Transplantation
  • "One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donors" (2021) in Haematologica
  • "ROCK2 Inhibition With Belumosudil (KD025) for the Treatment of Chronic Graft-Versus-Host Disease" (2021) in Journal of Clinical Oncology
  • "DNA Sequencing to Detect Residual Disease in Adults With Acute Myeloid Leukemia Prior to Hematopoietic Cell Transplant" (2023) in JAMA
  • "Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia" (2021) in Blood Advances

Their frequent co-authors include:

  • Shernan G. Holtan
  • Mukta Arora
  • Armin Rashidi
  • Najla El Jurdi
  • Margaret L. MacMillan

Daniel J. Weisdorf regularly publishes in journals specialized in transplantation and hematology. Frequent publication venues include:

  • Transplantation and Cellular Therapy
  • Blood
  • Blood Advances
  • Biology of Blood and Marrow Transplantation
  • Bone Marrow Transplantation

Best Publications

  • 1994 Consensus Conference on Acute GVHD Grading.

    Przepiorka D;Weisdorf D;Martin P;Klingemann Hg

  • National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and Staging Working Group Report

    Madan H. Jagasia;Hildegard T. Greinix;Mukta Arora;Kirsten M. Williams

  • National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease

    Madan H. Jagasia;Hildegard T. Greinix;Mukta Arora;Kirsten M. Williams

  • Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer.

    Jeffrey S. Miller;Yvette Soignier;Angela Panoskaltsis-Mortari;Sarah A. McNearney

  • Origins of circulating endothelial cells and endothelial outgrowth from blood

    Yi Lin;Daniel J. Weisdorf;Anna Solovey;Robert P. Hebbel

  • High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation.

    Stephanie J. Lee;John Klein;Michael Haagenson;Lee Ann Baxter-Lowe

  • Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival.

    John E. Wagner;Juliet N. Barker;Todd E. DeFor;K. Scott Baker

  • A Controlled Trial of Fluconazole to Prevent Fungal Infections in Patients Undergoing Bone Marrow Transplantation

    Jesse L. Goodman;Drew J. Winston;Ronald A. Greenfield;Pranatharthi H. Chandrasekar

  • Lenalidomide after stem-cell transplantation for multiple myeloma

    Philip L. McCarthy;Kouros Owzar;Craig C. Hofmeister;David D. Hurd

  • Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy

    Juliet N. Barker;Daniel J. Weisdorf;Todd E. DeFor;Bruce R. Blazar

  • Palifermin for Oral Mucositis after Intensive Therapy for Hematologic Cancers

    Ricardo Spielberger;Patrick Stiff;William Bensinger;Teresa Gentile

  • Peripheral-Blood Stem Cells versus Bone Marrow from Unrelated Donors

    Claudio Anasetti;Brent R. Logan;Stephanie J. Lee;Edmund K. Waller

  • Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome.

    Neal Flomenberg;Lee Ann Baxter-Lowe;Dennis Confer;Marcelo Fernandez-Vina

  • Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry.

    G Socié;J V Stone;J R Wingard;D Weisdorf

  • A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome

    Corey S. Cutler;Stephanie J. Lee;Peter Greenberg;H. Joachim Deeg

  • Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation

    Philippe Armand;Haesook T. Kim;Brent R. Logan;Zhiwei Wang

  • Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age

    Craig Kollman;Craig W. S. Howe;Claudio Anasetti;Joseph H. Antin

  • A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant

    Raleigh A. Bowden;Sherrill J. Slichter;Sherrill J. Slichter;Sherrill J. Slichter;Merlin Sayers;Merlin Sayers;Merlin Sayers;Daniel Weisdorf;Daniel Weisdorf;Daniel Weisdorf

  • Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study.

    Rochelle E. Curtis;Lois B. Travis;Philip A. Rowlings;Gérard Socié

  • Phase III Study Comparing Methotrexate and Tacrolimus (Prograf, FK506) With Methotrexate and Cyclosporine for Graft-Versus-Host Disease Prophylaxis After HLA-Identical Sibling Bone Marrow Transplantation

    Voravit Ratanatharathorn;Richard A. Nash;Donna Przepiorka;Steven M. Devine

Frequent Co-Authors

Todd E. DeFor
Todd E. DeFor University of Minnesota
John E. Wagner
John E. Wagner University of Minnesota
Jeffrey S. Miller
Jeffrey S. Miller University of Minnesota
Bruce R. Blazar
Bruce R. Blazar University of Minnesota
Michael R. Verneris
Michael R. Verneris University of Colorado Denver
Mary M. Horowitz
Mary M. Horowitz Medical College of Wisconsin
Mei-Jie Zhang
Mei-Jie Zhang Medical College of Wisconsin
Corey Cutler
Corey Cutler Harvard University
Stephanie J. Lee
Stephanie J. Lee Fred Hutchinson Cancer Research Center
Philip B. McGlave
Philip B. McGlave University of Minnesota

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in medical careers beyond traditional MD programs, online nursing degrees offer flexible entry points and specializations. Many students choose to start with practical credentials, such as an associate degree or RN, then advance to a BSN or higher degree. If cost is a concern, consider browsing the online nursing school options that make career advancement more accessible.

Highly motivated registered nurses may want to pursue the most affordable accredited online rn to bsn programs to elevate their skills and expand their career opportunities in clinical and leadership roles. If you’re interested in advanced practice, the cheapest online acute care nurse practitioner programs help prepare for specialized positions with increased responsibility and autonomy.

Those drawn to academia or high-level research can even explore online phd programs in nursing, typically designed for working professionals. Whether you’re just starting out or seeking career advancement, these online pathways provide quality education and flexibility for aspiring healthcare leaders.

Best Scientists Citing Daniel J. Weisdorf

Trending Scientists